Understand how metabolic peptides differ and what their findings mean. This upcoming PDF brings clear explanations, side-by-side comparisons and key takeaways together, with the evidence and its limits close at hand. Coming soon. The finished PDF is not available yet.
Who this is for
Readers who want to understand how metabolic peptides differ and make sense of human trial results. Start with clear definitions, then work through the studies at your own pace.
What the guide will cover
Receptors explained. What GLP-1, GIP and glucagon do, what an agonist means and how the targets differ.
Peptides compared side by side. See who was studied, which outcomes changed, and how the studies differ.
Key findings, explained. Understand percentage changes, reported side effects, and what the results can tell you.
Useful next questions. A reading worksheet to keep track of what you learned, what remains uncertain, and questions to discuss with a clinician.
A linked source index. Find the papers and trial records behind each section.
Start reading free
A fair comparison begins with the research question. Check who participated, what the control group received, what changed and when it was measured. A percentage without that context is difficult to interpret.
Read the Retatrutide profile · Understand study models
Release and format
The intended format is a PDF with linked references and a study-reading workbook. Final contents, price and release details will be published when it is ready.